← Scoopfeeds — Intelligent news, curated.
UBS reiterates Buy on Teva Pharma stock, keeps $42 price target
business

UBS reiterates Buy on Teva Pharma stock, keeps $42 price target

Investing.com · Jun 26, 2026, 2:24 PM · Also reported by 2 other sources

UBS reiterates Buy on Teva Pharma stock, keeps $42 price target

Read full story on Investing.com → More top stories

Also covered by

Yahoo Finance Prediction: SanDisk Has Rallied Too Far, Too Fast. The Price Target Warns of 20%+ Downside Yahoo Finance Stock Price Prediction: Super Micro Computer Set for 10% Climb After Repricing

More in business

Yahoo Finance
The Quiet Gross Margin Reality Check That Points to a Dangerous Valuation Gap Between Marvell and Broadcom
Yahoo Finance
The Bitcoin Mining ETF That Returned 52% in One Week, And Most Income Investors Have Never Heard of It
MarketWatch
How Micron aims to break through the risk cycle that has spooked investors for decades
Yahoo Finance
Want $7,000 a Year on $100K? These Pipelines Yield 7%+ While Your Cash Pays Less
CNBC
Trump threatens 100% tariff on countries putting 'Digital Services Tax on American Companies'
Aggregated and edited by the Scoop newsroom. We surface news from Investing.com alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop